Bank of America’s Genenta Science GNTA Stock Holding History

Bank of America’s Portfolio GNTA Stock Details GNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-343	Closed	-$1.89K	–	7978
2022 Q4	$1.89K	Buy	+343	New	+$1.69K	﹤0.01%	7255
2022 Q3	–	Sell	-381	Closed	-$3K	–	7984
2022 Q2	$3K	Sell	381 -30	-7%	-$203	﹤0.01%	7707
2022 Q1	$3K	Buy	+411	New	+$3.31K	﹤0.01%	7980

Other funds holding GNTA

Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's GNTA Position: Q1 2023 in Review

Bank of America sold out of Genenta Science (GNTA) in Q1 2023, closing a stake of 343 shares — an estimated $1.89K sold.

Bank of America first reported a position in GNTA in Q1 2022 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 2 funds tracked by Wall St. Rank hold GNTA as of Q1 2023.

Bank of America reported no remaining Genenta Science position as of Q1 2023 after selling out during the quarter.
Bank of America sold 343 Genenta Science shares in Q1 2023, an estimated $1.89K.
Bank of America first reported a position in Genenta Science in Q1 2022 and held it in 3 quarters.
Bank of America's Genenta Science position peaked at $3K in Q2 2022.
2 funds tracked by Wall St. Rank held Genenta Science as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.